112 related articles for article (PubMed ID: 29057309)
1. Direct pro-apoptotic role for NPM1 as a regulator of PIDDosome formation.
Sidi S; Bouchier-Hayes L
Mol Cell Oncol; 2017; 4(5):e1348325. PubMed ID: 29057309
[TBL] [Abstract][Full Text] [Related]
2. NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus.
Ando K; Parsons MJ; Shah RB; Charendoff CI; Paris SL; Liu PH; Fassio SR; Rohrman BA; Thompson R; Oberst A; Sidi S; Bouchier-Hayes L
J Cell Biol; 2017 Jun; 216(6):1795-1810. PubMed ID: 28432080
[TBL] [Abstract][Full Text] [Related]
3. An Inhibitor of PIDDosome Formation.
Thompson R; Shah RB; Liu PH; Gupta YK; Ando K; Aggarwal AK; Sidi S
Mol Cell; 2015 Jun; 58(5):767-79. PubMed ID: 25936804
[TBL] [Abstract][Full Text] [Related]
4. Identification and analysis of dominant negative mutants of RAIDD and PIDD.
Jang TH; Bae JY; Park OK; Kim JH; Cho KH; Jeon JH; Park HH
Biochim Biophys Acta; 2010 Jul; 1804(7):1557-63. PubMed ID: 20406701
[TBL] [Abstract][Full Text] [Related]
5. Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia.
Sakthivel D; Brown-Suedel AN; Keane F; Huang S; Sherry KM; Charendoff CI; Dunne KP; Robichaux DJ; Le B; Shin CS; Carisey AF; Flanagan JM; Bouchier-Hayes L
bioRxiv; 2023 May; ():. PubMed ID: 37398413
[TBL] [Abstract][Full Text] [Related]
6. A mitosis-sensing caspase activation platform? New insights into the PIDDosome.
Shah RB; Thompson R; Sidi S
Mol Cell Oncol; 2016 May; 3(3):e1059921. PubMed ID: 27314076
[TBL] [Abstract][Full Text] [Related]
7. PIDD mediates and stabilizes the interaction between RAIDD and caspase-2 for the PIDDosome assembly.
Jang TH; Park HH
BMB Rep; 2013 Sep; 46(9):471-6. PubMed ID: 24064063
[TBL] [Abstract][Full Text] [Related]
8. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
9. In vitro reconstitution of the interactions in the PIDDosome.
Jang TH; Zheng C; Wu H; Jeon JH; Park HH
Apoptosis; 2010 Dec; 15(12):1444-52. PubMed ID: 20872280
[TBL] [Abstract][Full Text] [Related]
10. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage.
Vakifahmetoglu H; Olsson M; Orrenius S; Zhivotovsky B
Oncogene; 2006 Sep; 25(41):5683-92. PubMed ID: 16652156
[TBL] [Abstract][Full Text] [Related]
11. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of neurodevelopmental disorders caused by pathogenic variants of PIDD.
Ha HJ; Park HH
Biochem Biophys Res Commun; 2023 Feb; 645():147-153. PubMed ID: 36689811
[TBL] [Abstract][Full Text] [Related]
13. Flexible stoichiometry and asymmetry of the PIDDosome core complex by heteronuclear NMR spectroscopy and mass spectrometry.
Nematollahi LA; Garza-Garcia A; Bechara C; Esposito D; Morgner N; Robinson CV; Driscoll PC
J Mol Biol; 2015 Feb; 427(4):737-752. PubMed ID: 25528640
[TBL] [Abstract][Full Text] [Related]
14. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
15. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
Du Pisani LA; Shires K
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
[TBL] [Abstract][Full Text] [Related]
16. Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia.
Wang L; Yang L; Yang Z; Tang Y; Tao Y; Zhan Q; Lei L; Jing Y; Jiang X; Jin H; Zou Q; Xian J; Zhang L
Int J Biol Sci; 2019; 15(4):882-894. PubMed ID: 30906218
[TBL] [Abstract][Full Text] [Related]
17. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
Falini B; Sportoletti P; Martelli MP
Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
[TBL] [Abstract][Full Text] [Related]
20. New insights into the biology of acute myeloid leukemia with mutated NPM1.
Brunetti L; Gundry MC; Goodell MA
Int J Hematol; 2019 Aug; 110(2):150-160. PubMed ID: 30632059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
